MAGELLAN LONGEVITY
HomeResearchStudy library › Can daily low-dose B vitamins plus betaine supplementation reduce…
Study summary · Cardiovascular & vascular aging

Can daily low-dose B vitamins plus betaine supplementation reduce plasma homocysteine concentrations in Chinese adults with hyperhomocysteinemia who are not exposed to mandatory folic acid fortification?

In one paragraph

Betaine (Eur J Nutr 2023, PMID 36717385) — after 12 weeks, the supplement group had a significant reduction in plasma homocysteine concentrations compared to the placebo group (mean group difference -3.87; reduction rate 10.1%). Scope: over 12 weeks, and the abstract states no limitations.

Source: Eur J Nutr 2023, PMID 36717385 ↗ · Research map · How Magellan grades evidence · evidence confidence: medium

Eur J Nutr · 2023 · PMID 36717385 · DOI 10.1007/s00394-023-03087-y

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Daily low-dose B vitamins and betaine supplementation can reduce high homocysteine levels in Chinese adults.

The question

Can daily low-dose B vitamins plus betaine supplementation reduce plasma homocysteine concentrations in Chinese adults with hyperhomocysteinemia who are not exposed to mandatory folic acid fortification?

What they tested

Daily supplementation with low-dose B vitamins plus betaine will significantly reduce plasma homocysteine concentrations in Chinese adults with hyperhomocysteinemia.

How they did it

One hundred healthy Chinese adults with hyperhomocysteinemia were randomly assigned to either a supplement group (400 μg folic acid, 8 mg vitamin B, 6.4 μg vitamin B, and 1 g betaine daily) or a placebo group for 12 weeks. Fasting blood was collected at baseline, week 4, and week 12 to measure homocysteine, folate, vitamin B, and betaine concentrations. Generalized estimation equations were used for statistical analysis.

What they found

The supplement group showed significant increases in blood folate, vitamin B, and betaine concentrations, indicating good compliance. At baseline, homocysteine levels were similar between groups. After 12 weeks, the supplement group had a significant reduction in plasma homocysteine concentrations compared to the placebo group (mean group difference -3.87; reduction rate 10.1%). This decrease was associated with increased blood folate and betaine concentrations.

What it means

Daily supplementation with low-dose B vitamins plus betaine for 12 weeks effectively decreased plasma homocysteine concentrations in Chinese adults with hyperhomocysteinemia.

Limitations

The abstract does not explicitly state any limitations of the study.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“low-dose B vitamins plus betaine effectively decreased plasma homocysteine”— from the published abstract, Eur J Nutr 2023

The paper at a glance

Magellan’s evidence labelmethyl donor, homocysteine remethylation (our label for this citation — see PubMed for the paper’s own title and authors)
JournalEur J Nutr
Year2023
PMID36717385 ↗
DOI10.1007/s00394-023-03087-y ↗
TopicCardiovascular & vascular aging

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Betaine (TMG)

Human trials and meta-analyses consistently show that oral betaine lowers fasting and post-methionine-load plasma homocysteine in a dose-dependent manner (about 1.2 µmol/L on average at 4 g/day and above), and a prescription form is FDA-approved for the rare genetic disorder homocystinuria;

Betaine (TMG)

Betaine, also called trimethylglycine (TMG), is a naturally occurring compound found in foods such as…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). Can daily low-dose B vitamins plus betaine supplementation reduce plasma homocysteine concentrations in Chinese adults with hyperhomocysteinemia who are not exposed to mandatory folic acid fortification? [Plain-English summary of Eur J Nutr 2023, PMID 36717385, DOI 10.1007/s00394-023-03087-y]. Magellan Longevity. https://magellanlongevity.com/study/s132.html
BibTeX
@misc{magellan_s132, title = {Can daily low-dose B vitamins plus betaine supplementation reduce plasma homocysteine concentrations in Chinese adults with hyperhomocysteinemia who are not exposed to mandatory folic acid fortification?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/s132.html}}, note = {Plain-English summary of PubMed PMID 36717385; DOI 10.1007/s00394-023-03087-y; Eur J Nutr 2023. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/s132.html

Related studies in the Magellan library

All 67 Magellan summaries on cardiovascular & vascular aging →

How this summary was made. Every section above restates what the published abstract of PMID 36717385 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.